Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters











Publication year range
1.
Bol. latinoam. Caribe plantas med. aromát ; 23(2): 304-325, mar. 2024. tab, graf
Article in English | LILACS | ID: biblio-1552604

ABSTRACT

The physicochemical, microbiological and metabolomics analysis, antioxidant and lipid - lowering effect, and shelf life prediction of a functional beverage based on cocona pul p of SRN9 ecotype was to carry out. According to the results obtained, the beverage complies with all the characteristics of the Peruvian technical standard for juices, nectars and fruit beverages NTP 203.110:2009 and is within the limits established by th e sanitary technical standard NTS N° 071 - MINSA/DIGESA - V.01, with a shelf - life period of 4 months and 1 day. The metabolome regarding bioactive compounds showed the presence of 30 compounds, including several glycosylated flavonols, two flavanols, and two s permidines. Likewise, showed a lipid - lowering effect statistically significant (p < 0.05) about the serum levels of total cholesterol and triglycerides, with a mean reduction of 41.52 mg/dL for total cholesterol levels and 130.80 mg/dL for triglyceride lev els. This beverage could be an alternative for the treatment of atherosclerosis and prevention of cardiovascular diseases.


Se rea lizó el análisis fisicoquímico, microbiológico y metabolómico, efecto antioxidante e hipolipemiante, y vida útil de una bebida funcional a base de cocona ecotipo SRN9. De acuerdo a los resultados, la bebida cumple con las características de la norma técnic a peruana para jugos, néctares y bebidas de frutas NTP 203.110:2009 y se encuentra dentro de los límites establecidos por la norma técnica sanitaria NTS N° 071 - MINSA/DIGESA - V.01, con una vida útil de 4 meses y 1 día. Del perfil metabolómico se identificaro n 30 compuestos, entre ellos varios flavonoles glicosilados, dos flavanoles y dos espermidinas. Asimismo, mostró un efecto hipolipemiante estadísticamente significativo (p < 0,05) sobre los niveles séricos de colesterol total y triglicéridos, con una reduc ción media de 41,52 mg/dL y de 130,80 mg/dL para los niveles de colesterol total y de triglicéridos, respectivamente. Esta bebida podría ser una alternativa para el tratamiento de la aterosclerosis y prevención de enfermedades cardiovasculares.


Subject(s)
Solanum/chemistry , Fruit and Vegetable Juices/analysis , Hypolipidemic Agents/pharmacology , Hypolipidemic Agents/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Phenols/analysis , Flavonols/analysis , Functional Food/analysis , Liquid Chromatography-Mass Spectrometry/methods , Hydrogen-Ion Concentration
2.
Bol. latinoam. Caribe plantas med. aromát ; 23(2): 273-290, mar. 2024. tab, graf
Article in English | LILACS | ID: biblio-1552583

ABSTRACT

The aim of the present study was to assess the impacts of roasting and the type of extraction solvent (ethanol or water) on the hypolipidemic act ivity of xoconostle fruit peel extracts in a tyloxapol - induced model of hyperlipidemia. Water and ethanol extracts from raw and roasted Opuntia joconostle peels were obtained to quantify the phytochemicals contained within and assess their hypolipidemic ac tivity in rats (n=5) against tyloxapol - induced dyslipidemia (400 mg/kg). The raw ethanol and water extracts, as well as the roasted water extract (200 mg/kg), showed hypolipidemic activity in the tyloxapol - treated group ( p <0.05). In contrast, the roasted s ample extracted with ethanol did not show this effect. The concentrations of phenolic compounds (39.80 mg GAE/g) and flavonoids (16.42 ± 0.14 mg QE/g) were higher in the ethanolic extracts than in the aqueous extracts. Conversely, the concentration of beta lains (115.51 ± 1.66 mg/100 g) was higher in the water extracts than in the ethanol extracts. It was concluded that the roasting process modified the concentration of some phytochemicals and their antioxidant capacity in vitro , producing a hypolipidemic ef fect in tyloxapol - induced hyperlipidemic rats


El objetivo del presente estudio fue evaluar el impacto del tostado y del tipo de disolvente de e xtracción (etanol o agua) sobre la actividad hipolipidémica de los extractos de cáscara de frutos de xoconostle en un modelo de hiperlipidemia inducido por el tyloxapol. Se obtuvieron extractos acuosos y etanólicos de cáscara cruda y asada de Opuntia jocon ostle para cuantificar los fitoquímicos que contienen y evaluar su actividad hipolipidémica en ratas (n=5) contra la dislipidemia inducida por el tyloxapol (400 mg/kg). Los extractos acuosos y etanólicos crudos, así como el extracto acuoso tostado (200 mg/ kg), mostraron actividad hipolipidémica en el grupo tratado con tiloxapol ( p <0,05). En cambio, la muestra asada y extraída con etanol no mostró este efecto. Las concentraciones de compuestos fenólicos (39,80 mg GAE/g) y flavonoides (16,42 ± 0,14 mg QE/g) f ueron mayores en los extractos etanólicos que en los acuosos. Por el contrario, la concentración de betalaínas (115,51 ± 1,66 mg/100 g) fue mayor en los extractos acuosos que en los etanólicos. Se concluyó que el proceso de asado modificó la concentración de algunos fitoquímicos y su capacidad antioxidante in vitro , produciendo un efecto hipolipidémico en ratas hiperlipidémicas inducidas por el tyloxapol.


Subject(s)
Animals , Mice , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Opuntia/chemistry , Dyslipidemias/drug therapy , Hypolipidemic Agents/administration & dosage , Phenols/analysis , Flavonoids/analysis , Water , Ethanol , Betalains/analysis , Liquid Chromatography-Mass Spectrometry , Hypolipidemic Agents/chemistry , Antioxidants
3.
Braz J Biol ; 84: e261518, 2022.
Article in English | MEDLINE | ID: mdl-36228225

ABSTRACT

Plants have profound therapeutic benefits, more economical treatments, fewer side effects, and a relatively cheap cost, making them a source of drugs for protective, preventative, curative, or conducive purposes and creating novel phytomedicines. Plant derived medicines are relatively safe compared to synthetic medicines. Many plants have proved to successfully aid in the treatment of diabetes including Filago hurdwarica (Wall. ex DC.) Wagenitz. The current investigations were therefore designed to assess the phytochemical, antioxidant, antidiabetic, and antihyperlipidemic activities of F. hurdwarica. The phytochemical investigations and antioxidant activities of different extracts were carried out using standard chemical tests, DPPH, and H2O2 scavenging assays. F. hurdwarica plant extract in Hydromethanolic solution were prepared by Soxhletation method and stored in refrigerator at 4°C for two days before use. Swiss Albino mice were made diabetic by a single dose of alloxan (150 mg/kg). Hydromethanolic plant extract and fractions of F. hurdwarica were screened for antidiabetic activity and given to the alloxan-induced diabetic mice at a concentration of 150-250 mg/kg of body weight in different groups of 6 diabetic mice each orally once a day for 15 days. Glibenclamide is also given to another group to as a standard drug to support the result at a dose of 10 mg/kg of body weight orally once a day for 15 days. Blood glucose levels and body weights of mice were measured on 0, 4, 7, 11 and 15th days. The study found that the extract was safe up to the dose level of 2000 mg/kg and the dose response effect of chloroform extract (150-250 mg/kg) of F. hurdwarica showed expressive antihyperglycemic effects and also improved other altered biochemical parameters associated with diabetes. The FTIR and XRD spectra demonstrated the occurrence of phenols, alcohols, alkenes, alkyl halides, ketones, and aromatic compounds and confirmed the amorphous nature of the extract. GC-MS spectral analysis showed the tentative presence of 31 phytochemical constituents in the chloroform extract of F. hurdwarica with different retention time. To conclude, the chloroform extract (250 mg/kg) of F. hurdwarica revealed considerable antioxidant, antihyperglycemic, and antihyperlipidemic potential and is safe for treating diabetes and related complications.


Subject(s)
Asteraceae , Diabetes Mellitus, Experimental , Alkenes/therapeutic use , Alloxan/therapeutic use , Animals , Antioxidants/pharmacology , Blood Glucose , Body Weight , Chloroform/therapeutic use , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Glyburide/therapeutic use , Hydrogen Peroxide/therapeutic use , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Hypolipidemic Agents/therapeutic use , Ketones/therapeutic use , Mice , Phenols/analysis , Phytochemicals/analysis , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
4.
Molecules ; 26(9)2021 Apr 21.
Article in English | MEDLINE | ID: mdl-33919145

ABSTRACT

The antihyperglycemic and antilipidemic effects of the tea infusion extracts of leaves from Annona cherimola Miller (IELAc-0.5, IELAc-1.5, and IELAc-3.0) were evaluated on normoglycemic (NG) and streptozocin-induced diabetic (STID) mice. In the acute test, IELAc-1.5 at 300 mg/kg bodyweight (bw) exhibited antihyperglycemic activity on STID mice since the first hour of treatment. Then, its antidiabetic potential was analyzed in a subchronic evaluation. IELAc-1.5 was able to reduce the blood glucose level, glycated hemoglobin (HbA1c), cholesterol (CHO), and triglycerides (TG); high-density lipoprotein (HDL) showed an increase at the end of treatment. IELAc-1.5 did not modify the urine profile at the end of the evaluation, and neither toxicity nor macroscopic organ damage were observed in acute and subchronic assays. In addition, a major flavonol glycoside present in the tea infusion extracts was identified using high-performance liquid chromatography with diode array detection (HPLC-DAD). The analysis of the tea infusion extracts by HPLC revealed that rutin was the major component. This study supports the use of tea infusions from Annona cherimola for the treatment of diabetes and suggests that rutin could be responsible, at least in part, for their antidiabetic properties.


Subject(s)
Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Plant Extracts/pharmacology , Animals , Annona/chemistry , Blood Glucose/drug effects , Body Weight/drug effects , Chromatography, High Pressure Liquid , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/metabolism , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/chemistry , Mice , Organ Size/drug effects , Plant Extracts/chemistry , Plant Leaves/chemistry , Tea
5.
Biomarkers ; 25(5): 417-424, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32519899

ABSTRACT

Aim: This study investigated the effects of polar Butia odorata fruit extract on metabolic, inflammatory, and oxidative stress parameters in rats submitted to a hyperlipidaemia condition induced by tyloxapol.Methods: Animals were divided into 3 groups: saline, saline plus tyloxapol, and B. odorata extract plus tyloxapol. Animals were treated for 15 days with a saline solution or B. odorata fruit extract and after hyperlipidaemia was induced by tyloxapol.Results: Treatment with B. odorata extract reduced serum triglyceride, total cholesterol, C-reactive protein, and adenosine deaminase and butyrylcholinesterase activities when compared to the tyloxapol group. HDL-cholesterol and paraoxonase 1 activity were higher in B. odorata extract treated animals when compared to tyloxapol-treated animals. No differences were observed in hepatic oxidative stress parameters. Phenolic compounds present in B. odorata fruit extract were identified and quantified by LC-MS/MS.Conclusion: These findings indicated that phenolic rich B. odorata extract has hypolipidemic and anti-inflammatory effects in hyperlipidemic rats.


Subject(s)
Arecaceae/chemistry , Aryldialkylphosphatase/genetics , Liver/drug effects , Oxidative Stress/drug effects , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , C-Reactive Protein/metabolism , Cholesterol, HDL/blood , Chromatography, Liquid , Fruit/chemistry , Humans , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Male , Phenols/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Tandem Mass Spectrometry , Triglycerides/blood
6.
J Liposome Res ; 29(3): 274-282, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30563398

ABSTRACT

The ethanolic extract obtained from purple pitanga fruit (Eugenia uniflora - PPE) has been previously described by its potential to reduce lipid accumulation in vitro. In this study, we aimed to study this potential in vivo using Caenorhabditis elegans as animal model. Considering the low pH of the extract, its hydrophilic characteristic, its absorption by the medium where the worms are cultivated and the need of a chronic exposure in the worms solid medium, we have loaded liposomes with PPE and investigated its potential for oral administration. Following 48 h exposure to the PPE-loaded liposomes on worms nematode growth medium, we did not observe any toxic effects of the formulation. Under high cholesterol diet, which increased worms total lipid and also triacylglycerides levels, liposomes containing PPE were able to significantly attenuate these alterations, which could not be observed when worms were treated with free PPE. Furthermore, we could evidence that liposomes were ingested by worms through their labelling to uranin fluorescence dye. Through total phenolic compounds quantification, we estimated an entrapment efficacy of PPE into liposomes of 87.7%. The high levels of phenolic compounds present in PPE, as previously described by our group, indicate that these antioxidants may interfere in worms lipid metabolism, which may occur through many and intricated mechanisms. Although the use of conventional liposomes for human consumption may not be pragmatic, its application for oral delivery of a hydrophilic substance in C. elegans was absolutely critical for our experimental design and has proven to be efficient.


Subject(s)
Caenorhabditis elegans/drug effects , Ethanol/chemistry , Eugenia/chemistry , Hypolipidemic Agents/chemistry , Lecithins/chemistry , Liposomes/chemistry , Phenols/chemistry , Plant Extracts/chemistry , Animals , Antioxidants/administration & dosage , Antioxidants/chemistry , Antioxidants/toxicity , Fruit/chemistry , Hydrophobic and Hydrophilic Interactions , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/toxicity , Particle Size , Phenols/administration & dosage , Phenols/toxicity , Plant Extracts/administration & dosage , Plant Extracts/toxicity , Solvents , Triglycerides/metabolism
7.
Molecules ; 23(11)2018 Oct 30.
Article in English | MEDLINE | ID: mdl-30380710

ABSTRACT

In Mexico one in 14 deaths are caused by diabetes mellitus (DM) or by the macro and microvascular disorders derived from it. A continuous hyperglycemic state is characteristic of DM, resulting from a sustained state of insulin resistance and/or a dysfunction of ß-pancreatic cells. Acaciella angustissima is a little studied species showing a significant antioxidant activity that can be used as treatment of this disease or preventive against the complications. The objective of this study was to explore the effect of oral administration of A. angustissima methanol extract on physiological parameters of streptozotocin-induced diabetic rats. The results indicated a significant reduction in blood glucose levels, an increase in serum insulin concentration, a decrease in lipid levels and an improvement in the parameters of kidney damage by applying a concentration of 100 mg/Kg B.W. However, glucose uptake activity was not observed in the adipocyte assay. Moreover, the extract of A. angustissima displayed potential for the complementary treatment of diabetes and its complications likely due to the presence of bioactive compounds such as protocatechuic acid. This study demonstrated that methanol extract of Acacciella angustissima has an antidiabetic effect by reducing the levels of glucose, insulin and improved physiological parameters, hypolipidemic effect, oxidative stress and renal damage in diabetic rats.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Fabaceae/chemistry , Hypolipidemic Agents/administration & dosage , Plant Extracts/administration & dosage , Animals , Blood Glucose/drug effects , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Fruit/chemistry , Humans , Hypolipidemic Agents/chemistry , Insulin/blood , Insulin Antagonists/administration & dosage , Insulin Antagonists/chemistry , Oxidative Stress/drug effects , Plant Extracts/chemistry , Rats
8.
Metab Brain Dis ; 33(5): 1551-1562, 2018 10.
Article in English | MEDLINE | ID: mdl-29882020

ABSTRACT

In this work, we evaluated the effects of Psidium cattleianum (Red Type) (PcRT) fruit extract on metabolic, behavioral, and neurochemical parameters in rats fed with a highly palatable diet (HPD) consisted of sucrose (65% carbohydrates being 34% from condensed milk, 8% from sucrose and 23% from starch, 25% protein and 10% fat). Animals were divided into 4 groups: standard chow, standard chow + PcRT extract (200 mg/Kg/day by gavage), HPD, HPD + extract. The animals were treated for 150 days. Concerning chemical profiling, LC/PDA/MS/MS analysis revealed cyanidin-3-O-glucoside as the only anthocyanin in the PcRT extract. Our results showed that the animals exposed to HPD presented glucose intolerance, increased weight gain and visceral fat, as well as higher serum levels of glucose, triacylglycerol, total cholesterol, LDL-cholesterol and interleukin-6. These alterations were prevented by PcRT. In addition, HPD caused an increase in immobility time in a forced swimming test and the fruit extract prevented this alteration, indicating an antidepressant-like effect. PcRT treatment also prevented increased acetylcholinesterase activity in the prefrontal cortex caused by HPD consumption. Moreover, PcRT extract was able to restore Ca2+-ATPase activity in the prefrontal cortex, hippocampus, and striatum, as well as Na+,K+-ATPase activity in the prefrontal cortex and hippocampus. PcRT treatment decreased thiobarbituric acid-reactive substances, nitrite, and reactive oxygen species levels and prevented the reduction of superoxide dismutase activity in all cerebral structures of the HPD group. Additionally, HPD decreased catalase in the hippocampus and striatum. However, the extract prevented this change in the hippocampus. Our results showed that this berry extract has antihyperglycemic and antihyperlipidemic effects, and neuroprotective properties, proving to be a potential therapeutic agent for individuals with metabolic syndrome.


Subject(s)
Anthocyanins/pharmacology , Antioxidants/pharmacology , Glucosides/pharmacology , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Metabolic Syndrome/drug therapy , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Psidium/chemistry , Animals , Anthocyanins/chemistry , Antidepressive Agents/chemistry , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Antioxidants/chemistry , Behavior, Animal/drug effects , Brazil , Catalase/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Diet, Carbohydrate Loading/adverse effects , Disease Models, Animal , Glucose Intolerance/chemically induced , Glucose Intolerance/drug therapy , Glucose Intolerance/metabolism , Glucosides/chemistry , Hippocampus/drug effects , Hippocampus/metabolism , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/therapeutic use , Metabolic Syndrome/chemically induced , Metabolic Syndrome/metabolism , Neuroprotective Agents/chemistry , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Tandem Mass Spectrometry , Weight Gain/drug effects
9.
Arch Pharm Res ; 40(5): 550-562, 2017 May.
Article in English | MEDLINE | ID: mdl-27943105

ABSTRACT

One new oleanolic acid derivative, 2α,3ß,23α,29α tetrahydroxyolean-12(13)-en-28-oic acid (1) was isolated from the aerial parts of Malva parviflora. Their structure was characterized by spectroscopic methods. The hypolipidemic and hypoglycemic activities of 1 was analyzed in in streptozotocin (STZ)-nicotinamide-induced type 2 diabetes in mice (MD) and type 1 diabetes in streptozotocin-induced diabetic mice (SD). Triterpene was administered orally at doses of 20 mg/kg for 4 weeks. Organ weight, body weight, glucose, fasting insulin, cholesterol-related lipid profile parameters, glutamate oxaloacetate transaminase (SGOT), glutamate pyruvate transaminase (SGPT), serum alkaline phosphatase (SALP), glucokinase, hexokinase, glucose-6-phosphatase activities and glycogen in liver were measured after 4 weeks of treatment. The results indicated that 1 regulate glucose metabolism, lipid profile, lipid peroxidation, increased body weight, glucokinase and hexokinase activities inhibited triglycerides, total cholesterol, low density lipoproteins level, SGOT, SGPT, SALP, glycogen in liver and glucose-6-phosphatase. In addition, improvement of insulin resistance and protective effect for pancreatic ß-cells, also 1 may changes the expression of pro-inflammatory cytokine (IL-6 and TNF-α levels) and enzymes (PAL2, COX-2, and LOX). The results suggest that 1 has hypolipidemic and hypoglycemic, anti-inflammatory, activities, improve insulin resistance and hepatic enzymes in streptozotocin-induced diabetic mice.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Malva/chemistry , Oleanolic Acid/pharmacology , Animals , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Type 2/chemically induced , Dose-Response Relationship, Drug , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/isolation & purification , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/isolation & purification , Male , Mice , Molecular Conformation , Oleanolic Acid/chemistry , Oleanolic Acid/isolation & purification , Streptozocin
10.
Oxid Med Cell Longev ; 2016: 9681425, 2016.
Article in English | MEDLINE | ID: mdl-27247703

ABSTRACT

High levels of reactive oxygen species in the body and hyperlipidemia are key factors for the development of cardiovascular diseases such as atherosclerosis. The present study investigated the antioxidant and hypolipidemic activity of hydroethanolic extract of Curatella americana L. leaves (ExC). The antioxidant activity of ExC was assessed by 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) scavenging capacity and protection against hemolysis induced by 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), followed by quantification of malondialdehyde (MDA). Wistar rats with hyperlipidemia induced by high-fructose diet (60%) were treated for 60 days with water, simvastatin (30 mg·Kg(-1)), ciprofibrate (2 mg·Kg(-1)), and ExC (200 mg·Kg(-1)). ExC revealed IC50 of 6.0 ± 0.5 µg·mL(-1), an intermediary value among positive controls used in the assay of DPPH scavenging capacity. At all concentrations (50 to 125 µg·mL(-1)) and times (60 to 240 min) evaluated, ExC protected erythrocytes against AAPH-induced hemolysis, which was confirmed by lower MDA levels. In vivo tests showed a reduction of 34 and 45%, respectively, in serum concentration of cholesterol and triglycerides in hyperlipidemic rats treated with ExC, a similar effect compared to the reference drugs, simvastatin and ciprofibrate, respectively. Together, the results showed the antioxidant activity of ExC and its ability to improve the serum lipid profile in hyperlipidemic rats.


Subject(s)
Antioxidants/chemistry , Dilleniaceae/chemistry , Hypolipidemic Agents/chemistry , Plant Extracts/chemistry , Animals , Antioxidants/pharmacology , Diet, Carbohydrate Loading , Dilleniaceae/metabolism , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/metabolism , Hemolysis/drug effects , Hyperlipidemias/drug therapy , Hyperlipidemias/etiology , Hypolipidemic Agents/therapeutic use , Lipid Peroxidation/drug effects , Lipids/blood , Malondialdehyde/analysis , Plant Extracts/pharmacology , Plant Leaves/chemistry , Plant Leaves/metabolism , Rats , Rats, Wistar , Simvastatin/pharmacology
11.
J Nutr Biochem ; 26(9): 893-902, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26048201

ABSTRACT

Supplementation with epigallocatechin-3-gallate (EGCG), which restores metabolic profiles, has been proposed as an option for preventing and treating obesity. We investigated whether decaffeinated green tea extract rich in EGCG, attenuates high-fat diet (HFD)-induced metabolic alterations in Swiss mice. The mice were maintained on either a control diet (CD) or HFD for 8 weeks and supplemented with either a placebo or EGCG (50mg/kg/day). Body weight, serum lipid profiles, cytokine protein expression, and content in epididymal (EPI) and retroperitoneal (RET) adipose tissues, and adipocyte area were measured. The body weights of HFD + placebo-fed mice were increased compared with those of HFD + EGCG-fed mice (28 and 21%, respectively), whereas the body weights of CD + EGCG-fed mice were decreased 16% compared with those of the CD + placebo group. Serum triglyceride levels were decreased 32% in the CD + EGCG group compared with the CD + placebo group. Compared with the CD + placebo group, increased phosphorylation of AMPK and hormone-sensitive lipase in EPI and RET, respectively, was found in the CD + EGCG group. Increased acetyl-CoA carboxylase phosphorylation was observed in both adipose tissues. In addition, TNF-α and IL-10 levels in EPI and adiponectin levels were higher in the CD + EGCG group than in the CD + placebo group. TNF-α levels were lower in the HFD + EGCG group than in the HFD + placebo group. Furthermore, the CD + EGCG group exhibited a lower adipocyte area than the CD + placebo group. These indicate that the effects of decaffeinated green tea extract on body mass may be related to the crosstalk between lipolytic and inflammatory pathways in normolipidic diet-fed mice but not in HFD-fed mice.


Subject(s)
Camellia sinensis/chemistry , Catechin/analogs & derivatives , Dietary Supplements , Food Handling , Hyperlipidemias/prevention & control , Hypolipidemic Agents/therapeutic use , Insulin Resistance , Absorption, Physicochemical , Adipose Tissue, White/immunology , Adipose Tissue, White/metabolism , Adipose Tissue, White/pathology , Adiposity , Animals , Anti-Obesity Agents/analysis , Anti-Obesity Agents/chemistry , Anti-Obesity Agents/isolation & purification , Anti-Obesity Agents/therapeutic use , Biomarkers/blood , Brazil , Catechin/analysis , Catechin/isolation & purification , Catechin/therapeutic use , Diet, High-Fat/adverse effects , Dietary Supplements/analysis , Hyperlipidemias/immunology , Hyperlipidemias/metabolism , Hyperlipidemias/pathology , Hypolipidemic Agents/analysis , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/isolation & purification , Male , Mice , Obesity/immunology , Obesity/metabolism , Obesity/pathology , Obesity/prevention & control , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Random Allocation , Weight Gain
12.
Water Sci Technol ; 71(8): 1143-50, 2015.
Article in English | MEDLINE | ID: mdl-25909723

ABSTRACT

The removal of two blood lipid regulators, clofibric acid (CLA) and gemfibrozil (GFZ), was evaluated using two identical aerobic membrane bioreactors with 6.5 L effective volume each. Polysulfone ultrafiltration hollow fiber membranes were submerged in the reactors. Different operating conditions were tested varying the organic load (F/M), hydraulic residence time (HRT), biomass concentration measured as total suspended solids in the mixed liquor (MLTSS) and the sludge retention time (SRT). Complete GFZ removal was obtained with F/M of 0.21-0.48 kg COD kgTSS⁻¹ d⁻¹, HRT of 4-10 hours, SRT of 10-32 d and MLTSS of 6-10 g L⁻¹. The GFZ removal can be attributed to biodegradation and there was no accumulation of the compound in the biomass. The CLA removals improved with the SRT and HRT increase and F/M decrease. Average removals of 78-79% were obtained with SRT 16-32 d, F/M of 0.21-0.34 kgCOD kgTSS⁻¹ d⁻¹, HRT of 7-10 hours and MLTSS of 6-10 g L⁻¹. Biodegradation was found to be the main removal pathway.


Subject(s)
Bioreactors , Clofibric Acid/chemistry , Gemfibrozil/chemistry , Membranes, Artificial , Waste Disposal, Fluid/methods , Water Pollutants, Chemical/chemistry , Biomass , Clofibric Acid/metabolism , Gemfibrozil/metabolism , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/metabolism , Sewage , Ultrafiltration/instrumentation , Ultrafiltration/methods
13.
J Ethnopharmacol ; 166: 286-96, 2015 May 26.
Article in English | MEDLINE | ID: mdl-25794806

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Cyclocarya paliurus (CP) Batal., the sole species in its genus, is a native plant to China. As a traditional Chinese folk medicine, the tree leaves have been widely used for the treatment of metabolic disorders, including hyperlipidemia, obesity, diabetes and hypertension. AIM OF THE STUDY: The study aimed to evaluate the antihyperlipidemic effect of CP ethanol extract, as well as its inhibitory activity on apolipoproteinB48 (apoB48), in normal and hyperlipidemic mice. MATERIALS AND METHODS: The antihyperlipidemic effect of CP was evaluated in hyperlipidemic mice induced by high-fat diet for 4 weeks. CP ethanol extract (0.37, 0.75 and 1.5g/kg/day) was orally administrated once daily. Lipids and antioxidant profiles, including total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), together with the indices of hepatic and renal functions were examined. RT-qPCR and western blotting were used to analysis the expression levels of tumor necrosis factor (TNF-α), total- and triglyceride-rich apoB48 (TRL-apoB48), as well as the phosphorylation of the mitogen-activatein kinase (MAPK). RESULTS: CP as well as simvastatin remarkably lowered the levels of TC, TG, LDL-C and MDA, and at the same time, elevated the HDL-C, SOD and GSH-Px in high-fat diet mice. It also decreased the serum concentration of total- and TRL-apoB48 in the fasting state. CP inhibited TNF-α expression and phosphorylation level of MAPK. Furthermore, the HE staining of liver and kidney, together with hepatic and renal function analysis showed hepato- and renoprotective activities of CP. CONCLUSIONS: These results suggested that CP possesses beneficial potentials for use in treating hyperlipidemia and the underlying lipid-lowering mechanism might associate with a down-regulation of the intestinal-associated lipoprotein apoB48, which may provide evidence about its practical application for treating hyperlipidemia and its complications.


Subject(s)
Apolipoprotein B-48/antagonists & inhibitors , Hyperlipidemias/drug therapy , Hypolipidemic Agents/pharmacology , Juglandaceae/chemistry , Plant Extracts/pharmacology , Animals , Antioxidants/metabolism , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet, High-Fat/adverse effects , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Ethnopharmacology/methods , Glutathione Peroxidase/blood , Hyperlipidemias/blood , Hyperlipidemias/metabolism , Hypolipidemic Agents/chemistry , Kidney/drug effects , Kidney/metabolism , Lipids/blood , Liver/drug effects , Liver/metabolism , Male , Malondialdehyde/blood , Mice , Mitogen-Activated Protein Kinase Kinases/metabolism , Plant Extracts/chemistry , Plant Leaves/chemistry , Superoxide Dismutase/blood , Triglycerides/blood , Tumor Necrosis Factor-alpha/metabolism
14.
J Med Food ; 17(2): 262-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24283277

ABSTRACT

The aim of this study was to evaluate the hypolipidemic effects of Myrciaria cauliflora peel flour (MPF) in rats. Previously, it was determined the proximate composition, total phenolics, and anthocyanins of MPF. Then, groups of male rats were randomly assigned to one of the five treatment groups. The standard group received a basal diet as recommended by the American Institute of Nutrition (AIN93M). The control group (CTRL) received the AIN93M diet, which added 7% of pork lard. The jaboticaba groups had their diets similar to CTRL, but added MPF at 7 (JAB1), 10 (JAB2), or 15% (JAB3). Serum and liver cholesterol as well as serum levels of high-density lipoprotein (HDL), triglycerides (TG), and glucose were evaluated. Fecal output of lipids was also measured. MPF had expressive amounts of fibers (25.28±2.52 g/100 g), total phenolics (18.95±5.27 mg/100 g), and anthocyanins (6.82±0.18 mg/100 g). The inclusion of the MPF at three ratios, reduced serum cholesterol and TG compared with CTRL. JAB3 raised serum HDL and reduced liver cholesterol compared with CTRL. JAB3 and JAB2 reduced serum glucose compared with CTRL. JAB groups eliminated more feces and had pH values lower than CTRL. However, there was no difference in lipid fecal output between all groups. MPF has a hypolipidemic potential, especially on reducing serum cholesterol and TG. These effects can be attributed, at least in part, to its fiber and phenolic composition.


Subject(s)
Flour/analysis , Hyperlipidemias/diet therapy , Hypolipidemic Agents/metabolism , Myrtaceae/chemistry , Animals , Cholesterol, HDL/metabolism , Diet, High-Fat/adverse effects , Dietary Fiber/analysis , Dietary Fiber/metabolism , Fruit/chemistry , Humans , Hyperlipidemias/metabolism , Hypolipidemic Agents/chemistry , Liver/metabolism , Male , Myrtaceae/metabolism , Rats , Triglycerides/metabolism
15.
Food Chem Toxicol ; 59: 256-60, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23770327

ABSTRACT

The aim of this study was to evaluate the effect of yacon (Smallanthus sonchifolius) (Poepp.& Endl.) on clinical parameters under diabetic conditions. The aqueous extract of yacon tuberous roots (YRAE; 0.76 g fructan kg⁻¹ body weight) was prepared at the moment of each administration. Thirty-two male rats were divided into four groups (n=8): control group (C); group that received YRAE (Y); untreated diabetic group (DM1); and diabetic group treated with YRAE (Y-DM1). The diabetes mellitus was induced by streptozotocin (60 mg kg⁻¹ body weight). The animals from Y2 and Y-DM1 received YRAE by gavage, at 7-day intervals, for 30 days. The aqueous extract of yacon roots decreased (p<0.05) the water and food intake in diabetic rats (Y-DM1). YRAE treatment reduced (p<0.05) glycaemia, total cholesterol, VLDL-c, LDL-c and triacylglycerol levels in diabetic rats (YRAE). HDL, urea and creatinine levels did not differ (p>0.05) between the Y and Y-DM1 groups. YRAE normalised alanine aminotransferase (ALT) activity, when comparing DM1 and Y-DM1 rats, but had no effect on lactate dehydrogenase activity (LDH). In conclusion, YRAE was sufficient for controlling water and food consumption, hyperglycaemia and dyslipidaemia, and promote the reduction of the ALT, suggesting a hepatoprotective effect in rats with STZ-induced DM1.


Subject(s)
Asteraceae/chemistry , Diabetes Mellitus, Type 1/drug therapy , Hyperglycemia/prevention & control , Hypoglycemic Agents/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Plant Roots/chemistry , Animals , Brazil , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/physiopathology , Dyslipidemias/complications , Dyslipidemias/prevention & control , Energy Intake/drug effects , Ethnopharmacology , Fructans/analysis , Hepatic Insufficiency/complications , Hepatic Insufficiency/prevention & control , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/therapeutic use , Liver/drug effects , Liver/physiopathology , Male , Medicine, Traditional , Phytotherapy/adverse effects , Plant Extracts/adverse effects , Plant Extracts/chemistry , Random Allocation , Rats , Rats, Wistar , Weight Loss/drug effects
16.
Lipids Health Dis ; 11: 98, 2012 Aug 06.
Article in English | MEDLINE | ID: mdl-22867128

ABSTRACT

BACKGROUND: Pentacyclic triterpenes in general exert beneficial effects in metabolic disorders. This study investigated the effects of α, ß-amyrin, a pentacyclic triterpene mixture from the resin of Protium heptaphyllum on blood sugar level and lipid profile in normal and streptozotocin (STZ)-induced diabetic mice, and in mice fed on a high-fat diet (HFD). FINDINGS: Mice treated with α, ß-amyrin (10, 30 and 100 mg/kg, p.o.) or glibenclamide (10 mg/kg, p.o.) had significantly reduced STZ-induced increases in blood glucose (BG), total cholesterol (TC) and serum triglycerides (TGs). Unlike glibenclamide that showed significant reductions in BG, TC and TGs in normoglycemic mice, α, ß-amyrin did not lower normal blood sugar levels but at 100 mg/kg, manifested a hypolipidemic effect. Also, α, ß-amyrin effectively reduced the elevated plasma glucose levels during the oral glucose tolerance test. Moreover, the plasma insulin level and histopathological analysis of pancreas revealed the beneficial effect of α, ß-amyrin in the preservation of beta cell integrity. In mice treated orally with α, ß-amyrin (10, 30 and 100 mg/kg) or fenofibrate (200 mg/kg), the HFD-associated rise in serum TC and TGs were significantly less. The hypocholesterolemic effect of α, ß-amyrin appeared more prominent at 100 mg/kg with significant decreases in VLDL and LDL cholesterol and an elevation of HDL cholesterol. Besides, the atherogenic index was significantly reduced by α, ß-amyrin. CONCLUSIONS: These findings reflect the potential antihyperglycemic and hypolipidemic effects of α, ß-amyrin mixture and suggest that it could be a lead compound for drug development effective in diabetes and atherosclerosis.


Subject(s)
Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Magnoliopsida/chemistry , Oleanolic Acid/analogs & derivatives , Animals , Blood Glucose/metabolism , Cholesterol/blood , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/pathology , Diet, High-Fat/adverse effects , Drug Discovery , Fenofibrate/pharmacology , Glyburide/pharmacology , Hypercholesterolemia/blood , Hypercholesterolemia/drug therapy , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/chemistry , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/pathology , Male , Mice , Oleanolic Acid/administration & dosage , Oleanolic Acid/chemistry , Oleanolic Acid/pharmacology , Phytotherapy , Triglycerides/blood
17.
Int J Food Sci Nutr ; 63(1): 125-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21809906

ABSTRACT

A spectrofluorimetric method for the determination of D,L-N-methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine, fluoxetine (F), in pharmaceuticals was evaluated in the 50.0-500.0 µg ml⁻¹ range. Linearity, sensibility, quantification and detection limit, and precision values are satisfactory. The method does not need pre-treatment and was successfully applied to the determination in pharmaceuticals and chitosan (Ch) solution. Ch has an ability to carry and absorb fat and may eventually be used together with F in slimming diets, and then interactions of Ch-F may occur. This work seeks to study these interactions by monitoring the photophysics of a drug in the presence of Ch. The results warn about the care that must be taken when both compounds are prescribed together.


Subject(s)
Chitosan/chemistry , Dietary Fats/metabolism , Fluoxetine/chemistry , Fluoxetine/isolation & purification , Hypolipidemic Agents/chemistry , Spectrometry, Fluorescence/methods , Chitosan/pharmacology , Diet, Reducing , Drug Interactions
18.
Chem Biol Interact ; 194(1): 31-9, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-21907189

ABSTRACT

Fructooligosaccharides (FOS) are sugars found naturally at high concentrations in the storage roots of yacon. This study was designed to analyze the beneficial effects of subchronic oral consumption of yacon root flour as a diet supplement in Streptozotocin-induced diabetic Wistar rats. The experiments were carried out using yacon flour tablets containing the desired level of FOS (340 or 6800mg FOS/kg body weight/day). Yacon flour is a natural product obtained by a simple process of dehydration of yacon roots without added preservatives or chemicals. The administration of FOS-rich yacon flour to diabetic rats for 90days did not significantly alter the body weight of animals throughout the experimental period. Interestingly, a significant decrease in fasting plasma triacylglycerol and very low-density lipoprotein levels were observed. In addition, the treatment was able to protect the diabetic rats of the postprandial peak of plasma triacylglycerol. Yacon-supplemented rats showed an increased insulin-positive pancreatic cell mass distributed in small cell clusters within the exocrine parenchyma, but can only observe a slight increase in fasting plasma insulin levels. Glucagon like peptide-1 content in the cecum was significantly higher in diabetic rats treated with a diet supplemented with yacon flour compared with untreated diabetic animals, accompanied by an important cecal tissue enlargement. All these findings lead us to suggest that this incretin could be an effective mediator of the lipid lowering effects of FOS present in yacon flour. In conclusion, yacon root flour is a natural product rich in FOS that could be well positioned as a nutraceutical product since the present results demonstrate its beneficial effects on diabetes-associated hyperlipidemia.


Subject(s)
Asteraceae/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypolipidemic Agents/therapeutic use , Oligosaccharides/therapeutic use , Plant Roots/chemistry , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Glucagon-Like Peptide 1/blood , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Insulin/blood , Lipoproteins, VLDL/blood , Male , Oligosaccharides/chemistry , Oligosaccharides/pharmacology , Rats , Rats, Wistar , Time Factors , Triglycerides/blood
19.
Chem Biodivers ; 8(1): 73-94, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21259421

ABSTRACT

Myrtaceae family (121 genera, 3800-5800 spp.) is one of the most important families in tropical forests. They are aromatic trees or shrubs, which frequently produce edible fruits. In the neotropics, ca. 1000 species were found. Several members of this family are used in folk medicine, mainly as an antidiarrheal, antimicrobial, antioxidant, cleanser, antirheumatic, and anti-inflammatory agent and to decrease the blood cholesterol. In addition, some fruits are eaten fresh or used to make juices, liqueurs, and sweets very much appreciated by people. The flavor composition of some fruits belonging to the Myrtaceae family has been extensively studied due to their pleasant and intense aromas. Most of the essential oils of neotropical Myrtaceae analyzed so far are characterized by predominance of sesquiterpenes, some with important biological properties. In the present work, chemical and pharmacological studies carried out on neotropical Myrtaceae species are reviewed, based on original articles published since 1980. The uses in folk medicine and chemotaxonomic importance of secondary metabolites are also briefly discussed.


Subject(s)
Myrtaceae/chemistry , Oils, Volatile/chemistry , Plant Oils/chemistry , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Antidiarrheals/chemistry , Antidiarrheals/pharmacology , Antioxidants/chemistry , Antioxidants/pharmacology , Antirheumatic Agents/chemistry , Antirheumatic Agents/pharmacology , Fruit/chemistry , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Medicine, Traditional , Oils, Volatile/pharmacology , Plant Oils/pharmacology
20.
Eur J Med Chem ; 42(10): 1263-71, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17448573

ABSTRACT

New arylidene-thiazolidinediones (ATZDs) were synthesized and evaluated in the alloxan-induced hyperglycemia mice model. The molecular target taken into consideration is the nuclear PPAR-gamma whose crystallographic structure is available on the PDB database as 2PRG. Thus the hypoglycemic and hypolipidemic activities of compounds were compared with the result of their docking after removal of the co-crystallized ligand present in the 2PRG structure. Molecular modeling studies were carried out using the Autodock 3.0.5 and ADT 1.1 programs.


Subject(s)
Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/chemical synthesis , Hypolipidemic Agents/therapeutic use , Thiazolidinediones/chemical synthesis , Thiazolidinediones/therapeutic use , Alloxan/pharmacology , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Dose-Response Relationship, Drug , Hydrogen Bonding , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/chemistry , Ligands , Mice , Models, Molecular , Molecular Structure , PPAR alpha/metabolism , PPAR gamma/metabolism , Thiazolidinediones/chemistry , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL